Injectable PrEP (Cabotegravir): The Long-Acting HIV Prevention Option Explained

You have probably already looked into the daily pill. Maybe you tried it for a while and the routine fell apart somewhere between flight connections and late nights. Maybe you share a room or a house with someone and would rather keep your HIV prevention to yourself. Or maybe you just want to hand the job over to a clinic every eight weeks and stop thinking about it entirely. That is a completely reasonable thing to want, and it is exactly what a lot of our patients here tell us when they walk in.

The answer to all of those situations is the same: cabotegravir long-acting injectable, also called CAB-LA or Apretude. It is one of the most meaningful changes in HIV prevention in recent years, and it is available right here in Pattaya.

What Injectable PrEP Actually Is

Cabotegravir is a drug that blocks HIV from establishing itself in your body if you are exposed. One injection every two months keeps protective levels in your system continuously. You do not need to do anything in between.

This is not experimental. CAB-LA has regulatory approval in multiple countries and was evaluated in large clinical trials, including HPTN 083 and HPTN 084, involving tens of thousands of participants. The evidence behind it is solid.

How the Dosing Schedule Works

This is the part people most often get wrong, so let us be clear about it. You do not get one shot and come back in two months. There is an initiation period first.

Your first injection is given at your appointment. You return exactly four weeks later for your second. After that, you are on the every-two-months schedule. If you miss a scheduled injection by more than a few weeks, you will need to be re-evaluated before continuing. Staying on schedule is what makes this medication work.

Injectable PrEP vs Oral PrEP: Choosing What Fits Your Life in Pattaya

Both options work well when used correctly. The difference is what you can realistically maintain.

Oral PrEP requires a pill every day. For people with consistent routines, it is affordable and effective. For people who travel, work irregular hours, or simply forget, the gaps are where real-world protection starts to slip.

Injectable PrEP removes that variable entirely. Eight weeks between injections means eight weeks where you do not think about it at all. A lot of the long-term expats we see in Pattaya prefer it precisely because their lives are not built around daily routines. Some tourists on longer stays start with oral PrEP and switch after one trip proves how hard it is to maintain across time zones and late nights.

Neither option is universally better. It depends on you. Come in and we will talk through it.

Why Having a Local Provider in Pattaya Matters

Every two months means every two months. If your only option is a Bangkok clinic, that is a round trip every eight weeks for as long as you stay on injectable PrEP. For anyone based in Pattaya, Jomtien, Naklua, or Pratumnak, that barrier is real, and barriers lead to missed doses.

Having access to injectable PrEP locally is not just a convenience. It is a clinical point. Consistent scheduling is what makes the medication effective. Doctor Pattaya offers injectable PrEP with full pre-screening, initiation injections, and ongoing follow-up available without the Bangkok trip. Walk-in consultations are welcome, and a same-day appointment is straightforward to arrange if you want to talk it through before committing.

What Happens at Your Appointment

At your first visit, we confirm you are HIV-negative with a same-day antigen and antibody test. We also check kidney function, hepatitis B status, and run a general sexual health screen. Most results come back the same day or the next morning, and for most patients we can give the first injection at that visit or the one immediately after.

The injection goes into the muscle, usually the buttock. Most patients find it more uncomfortable than a regular vaccine but manageable. Some soreness, swelling, or redness at the injection site is common in the days after, especially after the first two doses. Mild headache, fatigue, or nausea occur in some patients and usually clear within a few days.

At every follow-up injection appointment, we recheck your HIV status and do any additional monitoring that is clinically indicated. This is standard protocol, not optional.

Am I Eligible for Injectable PrEP?

You need to be HIV-negative before starting, confirmed by testing. Injectable PrEP is not a treatment for existing HIV infection, and giving it to someone who is already HIV-positive can contribute to drug resistance. We test before every initiation.

Beyond that, most healthy adults at ongoing HIV risk are eligible. We review your medical history for any contraindications and drug interactions. Hepatitis B status matters too. Some oral PrEP medications also treat hepatitis B, and switching from oral to injectable without addressing this can cause a hepatitis B flare. We check for this before you start.

Risks, Side Effects, and the Drug Resistance Tail

Injection site reactions are the most common side effect: pain, swelling, and warmth that usually improve with subsequent doses. Rare but serious effects include liver enzyme changes and hypersensitivity reactions. If you develop a rash, difficulty breathing, or significant abdominal pain after an injection, contact us straight away or go to the nearest emergency facility.

There is one more thing worth understanding before you start. When you stop CAB-LA, the drug does not leave your body immediately. It stays at low, sub-protective levels for weeks to months after your last injection. If you were exposed to HIV during this period, the residual drug could select for a drug-resistant strain rather than preventing infection. This is called the drug resistance tail, and it is why stopping injectable PrEP is not simply a matter of skipping your next appointment. Talk to us before you stop, and we will advise on whether transitioning back to oral PrEP makes sense for your situation.

What Injectable PrEP Does Not Cover

Cabotegravir prevents HIV. It does not prevent gonorrhoea, chlamydia, syphilis, herpes, or any other sexually transmitted infection. In Pattaya, where STI exposure risk is genuinely elevated, this distinction matters.

Condoms alongside injectable PrEP give you protection across the full range of STIs, not just HIV. Regular STI testing is still recommended even on injectable PrEP, because many infections have no symptoms and go undetected without a test. Our STI screening and STD treatment services are available at the same clinic, so you can keep your full sexual health picture clear alongside your HIV prevention.

Managing Your Schedule as a Tourist or Short-Stay Visitor

The most common question from visitors is: what if I cannot stay in Thailand for the full initiation period?

Your first injection can be given during your visit. The second initiation dose, due four weeks later, can be given at a qualified clinic in your home country, provided you carry documentation of your first dose including the date and batch number. After initiation, every-two-month follow-ups can similarly be managed across borders with proper coordination between providers.

If you are leaving Thailand before your second dose and need help planning the handover, tell us at your first appointment. We will give you a clinical summary to take to your next provider. We handle this regularly for patients passing through Pattaya on longer trips.

Cost of Injectable PrEP in Pattaya

Injectable PrEP costs more than oral PrEP. The medication itself is more expensive, and you need to factor in two-monthly clinic appointments alongside the injection cost.

Private clinic pricing in Thailand runs broadly in the range of 13,000 to 16,000 THB per injection, in line with Bangkok private clinic rates. Contact Doctor Pattaya directly for current pricing, as costs can shift with medication supply and exchange rates. For patients who have struggled with daily pill adherence in the past, the consistency injectable PrEP offers can represent genuine value.

What Is Coming Next in Long-Acting HIV Prevention

Lenacapavir is the name you will start hearing more often. It is a long-acting injectable HIV prevention drug currently in late-stage trials, with early results suggesting twice-yearly dosing may eventually be possible. It is not yet widely available as a PrEP option in Thailand, but it represents where things are heading. We will update our guidance as access develops.